It's Q4 earnings season, and several medtech firms have reported financials this week, including Edwards Lifesciences, Stryker, Boston Scientific... read more
Thu, 02/2/23 - 01:26 pm
As the second leading infectious killer after COVID-19, tuberculosis (TB) is considered a major worldwide health threat – accounting for nearly two million deaths annually, according to the... read more
Novartis has signed a deal with the Medicines Patent Pool to allow generic production of its patented drug Tasigna (nilotinib) to treat chronic myeloid leukemia (CML). This landmark agreement... read more
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,